Author:
Fagherazzi Guy,Zhang Lu,Aguayo Gloria,Pastore Jessica,Goetzinger Catherine,Fischer Aurélie,Malisoux Laurent,Samouda Hanen,Bohn Torsten,Ruiz-Castell Maria,Huiart Laetitia
Abstract
AbstractGiven the rapid increase in the incidence of cardiometabolic conditions, there is an urgent need for better approaches to prevent as many cases as possible and move from a one-size-fits-all approach to a precision cardiometabolic prevention strategy in the general population. We used data from ORISCAV-LUX 2, a nationwide, cross-sectional, population-based study. On the 1356 participants, we used a machine learning semi-supervised cluster method guided by body mass index (BMI) and glycated hemoglobin (HbA1c), and a set of 29 cardiometabolic variables, to identify subgroups of interest for cardiometabolic health. Cluster stability was assessed with the Jaccard similarity index. We have observed 4 clusters with a very high stability (ranging between 92 and 100%). Based on distinctive features that deviate from the overall population distribution, we have labeled Cluster 1 (N = 729, 53.76%) as “Healthy”, Cluster 2 (N = 508, 37.46%) as “Family history—Overweight—High Cholesterol “, Cluster 3 (N = 91, 6.71%) as “Severe Obesity—Prediabetes—Inflammation” and Cluster 4 (N = 28, 2.06%) as “Diabetes—Hypertension—Poor CV Health”. Our work provides an in-depth characterization and thus, a better understanding of cardiometabolic health in the general population. Our data suggest that such a clustering approach could now be used to define more targeted and tailored strategies for the prevention of cardiometabolic diseases at a population level. This study provides a first step towards precision cardiometabolic prevention and should be externally validated in other contexts.
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. IDF Diabetes Atlas 9th edition 2019. (Accessed 1 July 2021); https://www.diabetesatlas.org/en/.
2. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Obstetr. Gynecol. Surv. 58(3), 182–183 (2003).
3. Shubrook, J. H., Chen, W. & Lim, A. Evidence for the prevention of type 2 diabetes mellitus. J. Am. Osteopath. Assoc. 118, 730–737 (2018).
4. Diaz, K. M. & Shimbo, D. Physical activity and the prevention of hypertension. Curr. Hypertens. Rep. 15, 659–668 (2013).
5. Sánchez, A., Silvestre, C., Campo, N., Grandes, G. & PreDE Research Group. Type-2 diabetes primary prevention program implemented in routine primary care: A process evaluation study. Trials 17, 254 (2016).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献